{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T17:55:03Z","timestamp":1793987703903,"version":"4.8.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.diabres.2026.113216","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T16:34:40Z","timestamp":1773765280000},"page":"113216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Navigating the discordance: a comprehensive review of HbA1c-glycemia mismatch in clinical practice"],"prefix":"10.1016","volume":"235","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2345-9493","authenticated-orcid":false,"given":"Pichakacheri","family":"Sureshkumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidharth S.","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Anusree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johny","family":"Cheriyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asif","family":"Masood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2026.113216_b0005","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee. 6. Glycemic goals and hypoglycemia: standards of care in diabetes-2024. Diabetes Care. 2024;47(Supplement_1):S111\u2013S125. DOI: 10.2337\/dc24-S006.","DOI":"10.2337\/dc24-S006"},{"issue":"11","key":"10.1016\/j.diabres.2026.113216_b0010","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.4158\/EP161267.OR","article-title":"Performance of A1c versus OGTT for the diagnosis of prediabetes in a community-based screening","volume":"22","author":"Camacho","year":"2016","journal-title":"Endocr Pract"},{"issue":"7","key":"10.1016\/j.diabres.2026.113216_b0015","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.2337\/dci19-0023","article-title":"The cardiovascular legacy of good glycemic control: clues about mediators from the DCCT\/EDIC study","volume":"42","author":"Riddle","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2026.113216_b0020","doi-asserted-by":"crossref","unstructured":"Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, et al. Diabetes control and complications trial\/epidemiology of diabetes interventions and complications (DCCT\/EDIC) study research group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353(25):2643-53. DOI: 10.1056\/NEJMoa052187.","DOI":"10.1056\/NEJMoa052187"},{"key":"10.1016\/j.diabres.2026.113216_b0025","doi-asserted-by":"crossref","unstructured":"The Diabetes Control and Complications Trial (DCCT) Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977-986. DOI: 10.1056\/NEJM199309303291401.","DOI":"10.1056\/NEJM199309303291401"},{"issue":"9","key":"10.1016\/j.diabres.2026.113216_b0030","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1515\/CCLM.2003.182","article-title":"Haemoglobin A1c- a marker for complications of type 2 diabetes: the experience from the UK prospective diabetes study (UKPDS)","volume":"41","author":"Manley","year":"2003","journal-title":"Clin Chem Lab Med"},{"issue":"12","key":"10.1016\/j.diabres.2026.113216_b0035","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.2337\/dc09-zb12","article-title":"A1C: recommendations, debates, and questions","volume":"32","author":"Bloomgarden","year":"2009","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.diabres.2026.113216_b0040","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.2337\/dci24-0063","article-title":"History of the diabetes control and complications trial and its follow-up epidemiology of diabetes interventions and complications study: studies that changed the treatment of type 1 diabetes","volume":"47","author":"Nathan","year":"2024","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.diabres.2026.113216_b0045","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.2337\/dc14-1844","article-title":"The hemoglobin glycation index identifies subpopulations with harms or benefits from intensive treatment in the ACCORD trial","volume":"38","author":"Hempe","year":"2015","journal-title":"Diabetes Care"},{"issue":"Suppl 2","key":"10.1016\/j.diabres.2026.113216_b0050","doi-asserted-by":"crossref","first-page":"S184","DOI":"10.2337\/dc11-s216","article-title":"The pros and cons of diagnosing diabetes with A1C","volume":"34 Suppl 2","author":"Bonora","year":"2011","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.diabres.2026.113216_b0055","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.2337\/dc18-1581","article-title":"Glucose management indicator (GMI): a new term for estimating A1C from continuous glucose monitoring","volume":"41","author":"Bergenstal","year":"2018","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.diabres.2026.113216_b0060","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/1753-0407.12823","article-title":"Association of characteristics of people with type 2 diabetes mellitus with discordant values of fasting glucose and HbA1c","volume":"10","author":"Rathmann","year":"2018","journal-title":"J Diabetes"},{"issue":"4","key":"10.1016\/j.diabres.2026.113216_b0065","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1089\/dia.2020.0501","article-title":"HbA1c and glucose management indicator discordance: a real-world analysis","volume":"23","author":"Perlman","year":"2021","journal-title":"Diabetes Technol Ther"},{"issue":"6","key":"10.1016\/j.diabres.2026.113216_b0070","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1177\/19322968221092050","article-title":"Discordance between glycated hemoglobin A1c and the glucose management indicator in people with diabetes and chronic kidney disease","volume":"17","author":"Oriot","year":"2023","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.diabres.2026.113216_b0075","doi-asserted-by":"crossref","DOI":"10.1177\/20420188241252546","article-title":"HbA1c overestimates the glucose management indicator: a pilot study in patients with diabetes, chronic kidney disease not on dialysis, and anemia using is CGM","volume":"15","author":"G\u00f3mez Medina","year":"2024","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.diabres.2026.113216_b0080","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jcjd.2025.08.002","article-title":"Assessment of clinical factors influencing glucose management indicator and glycated hemoglobin discordance in children with type 1 diabetes: a 1-year, real-world data observation","volume":"49","author":"Deja","year":"2025","journal-title":"Can J Diabetes"},{"issue":"5","key":"10.1016\/j.diabres.2026.113216_b0085","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1177\/1932296820931825","article-title":"Time in specific glucose ranges, glucose management indicator, and glycemic variability: impact of continuous glucose monitoring (CGM) system model and sensor on CGM metrics","volume":"15","author":"Pleus","year":"2021","journal-title":"J Diabetes Sci Technol"},{"issue":"7","key":"10.1016\/j.diabres.2026.113216_b0090","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.2337\/dc25-0129","article-title":"A comparative analysis of glycemic metrics derived from three continuous glucose monitoring systems","volume":"48","author":"Freckmann","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2026.113216_b0095","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee for Diabetes. 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes- 2026. Diabetes Care. 2026;49 (Supplement_1):S132\u2013S149. DOI: 10.2337\/dc26-S006.","DOI":"10.2337\/dc26-S006"},{"issue":"6","key":"10.1016\/j.diabres.2026.113216_b0100","doi-asserted-by":"crossref","first-page":"906","DOI":"10.2337\/dci23-0086","article-title":"The glucose management indicator: time to change course?","volume":"47","author":"Selvin","year":"2024","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.diabres.2026.113216_b0105","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nrendo.2010.126","article-title":"Pitfalls in the use of HbA1(c) as a diagnostic test: the ethnic conundrum","volume":"6","author":"Dagogo-Jack","year":"2010","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"10.1016\/j.diabres.2026.113216_b0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0285336","article-title":"Prevalence of anemia in diabetes mellitus in South Asia: a systematic review and meta-analysis","volume":"18","author":"Mazumder","year":"2023","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.diabres.2026.113216_b0115","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1515\/CCLM.2010.144","article-title":"Glycated hemoglobin (HbA1c): old dogmas, a new perspective?","volume":"48","author":"Lippi","year":"2010","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.diabres.2026.113216_b0120","doi-asserted-by":"crossref","unstructured":"NCD Risk Factor Collaboration (NCD-RisC). Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c. Nat Med. 2023;29(11):2885-2901. DOI: 10.1038\/s41591-023-02610-2.","DOI":"10.1038\/s41591-023-02610-2"},{"issue":"1","key":"10.1016\/j.diabres.2026.113216_b0125","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1186\/s12889-025-22439-3","article-title":"Prevalence of anemia in India: a systematic review, meta-analysis and geospatial analysis","volume":"25","author":"Jeevan","year":"2025","journal-title":"BMC Public Health"},{"key":"10.1016\/j.diabres.2026.113216_b0130","article-title":"Prevalence of Sickle cell disease, Sickle cell trait and HBS-beta-thalassemia in India: a systematic review and meta-analysis","volume":"28","author":"Rao","year":"2024","journal-title":"Clin Epidemiol Global Health"},{"issue":"3","key":"10.1016\/j.diabres.2026.113216_b0135","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ejmhg.2016.01.004","article-title":"Prevalence of glucose-6-phosphate dehydrogenase deficiency in India: an updated meta-analysis","volume":"17","author":"Kumar","year":"2016","journal-title":"Egypt J Med Hum Genet"},{"issue":"5","key":"10.1016\/j.diabres.2026.113216_b0140","doi-asserted-by":"crossref","first-page":"516","DOI":"10.4103\/0971-5916.159499","article-title":"Glucose-6-phosphate dehydrogenase (G6PD) deficiency among tribal populations of India - country scenario","volume":"141","author":"Mukherjee","year":"2015","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.diabres.2026.113216_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.lansea.2026.100724","article-title":"The limitations and fallacies of relying on glycosylated hemoglobin for diagnosing and monitoring diabetes in Indian populations","volume":"45","author":"Samajdar","year":"2026","journal-title":"The Lancet Regional Health - Southeast Asia"},{"key":"10.1016\/j.diabres.2026.113216_b0150","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.diabres.2019.05.026","article-title":"Isolated HbA1c identifies a different subgroup of individuals with type 2 diabetes compared to fasting or post-challenge glucose in Asian Indians: the CARRS and MASALA studies","volume":"153","author":"Gujral","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"10.1016\/j.diabres.2026.113216_b0155","doi-asserted-by":"crossref","first-page":"110","DOI":"10.7326\/ANNALS-24-01661","article-title":"Misuse of race in the interpretation of HbA1c","volume":"178","author":"Selvin","year":"2025","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.diabres.2026.113216_b0160","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/1753-0407.12843","article-title":"Discordance between HbA1c and glycemia","volume":"10","author":"Misra","year":"2018","journal-title":"J Diabetes"},{"issue":"2","key":"10.1016\/j.diabres.2026.113216_b0250","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3949\/ccjm.88a.19135","article-title":"How should you assess glycemic control if the hemoglobin A1c is inaccurate or uninterpretable?","volume":"88","author":"Henderson","year":"2021","journal-title":"Cleve Clin J Med"},{"issue":"2","key":"10.1016\/j.diabres.2026.113216_b0235","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/1932296814567227","article-title":"Advantages and pitfalls of fructosamine and glycated albumin in the diagnosis and treatment of diabetes","volume":"9","author":"Danese","year":"2015","journal-title":"J Diabetes Sci Technol"},{"issue":"8","key":"10.1016\/j.diabres.2026.113216_b0165","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.2337\/dc06-0286","article-title":"Evidence for independent heritability of the glycation gap (glycosylation gap) fraction of HbA1c in nondiabetic twins","volume":"29","author":"Cohen","year":"2006","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.diabres.2026.113216_b0170","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.2337\/dc25-0556","article-title":"Undiagnosed G6PD deficiency in black and Asian individuals is prevalent and contributes to health inequalities in type 2 diabetes diagnosis and complications","volume":"48","author":"Martin","year":"2025","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.diabres.2026.113216_b0175","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2337\/dc06-1612","article-title":"The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes","volume":"30","author":"Monnier","year":"2007","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.diabres.2026.113216_b0180","doi-asserted-by":"crossref","first-page":"e166","DOI":"10.1038\/nutd.2015.16","article-title":"Implications of iron deficiency\/anemia on the classification of diabetes using HbA1c","volume":"5","author":"Attard","year":"2015","journal-title":"Nutr Diabetes"},{"key":"10.1016\/j.diabres.2026.113216_b0185","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cca.2012.12.026","article-title":"The long and winding road to optimal HbA1c measurement","volume":"418","author":"Little","year":"2013","journal-title":"Clin Chim Acta"},{"issue":"11","key":"10.1016\/j.diabres.2026.113216_b0190","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.2337\/dc10-0917","article-title":"The effect of iron and erythropoietin treatment on the A1C of patients with diabetes and chronic kidney disease","volume":"33","author":"Ng","year":"2010","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.diabres.2026.113216_b0195","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s11606-013-2595-x","article-title":"Pitfalls in hemoglobin A1c measurement: when results may be misleading","volume":"29","author":"Radin","year":"2014","journal-title":"J Gen Intern Med"},{"issue":"1","key":"10.1016\/j.diabres.2026.113216_b0200","doi-asserted-by":"crossref","first-page":"91","DOI":"10.4103\/ijem.IJEM_190_18","article-title":"Impact of anemia and red cell indices on the diagnosis of pre-diabetes and diabetes in indian adult population: is there a cut-off guide for clinicians?","volume":"23","author":"Kannan","year":"2019","journal-title":"Indian J Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.diabres.2026.113216_b0205","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/193229680900300306","article-title":"A review of the challenge in measuring hemoglobin A1c","volume":"3","author":"Weykamp","year":"2009","journal-title":"J Diabetes Sci Technol"},{"issue":"1","key":"10.1016\/j.diabres.2026.113216_b0210","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41572-019-0098-8","article-title":"Gestational diabetes mellitus","volume":"5","author":"McIntyre","year":"2019","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"10.1016\/j.diabres.2026.113216_b0215","doi-asserted-by":"crossref","DOI":"10.1111\/dme.70023","article-title":"Managing discordance between HbA1c and glucose management indicator","volume":"42","author":"Lenters-Westra","year":"2025","journal-title":"Diabet Med"},{"issue":"11","key":"10.1016\/j.diabres.2026.113216_b0220","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1111\/j.1464-5491.2012.03634.x","article-title":"Accuracy of glycated haemoglobin in screening for pre-diabetes in Asian Indians\u2013a community survey: the Chandigarh Urban Diabetes Study (CUDS)","volume":"29","author":"Bhansali","year":"2012","journal-title":"Diabet Med"},{"issue":"2","key":"10.1016\/j.diabres.2026.113216_b0225","doi-asserted-by":"crossref","first-page":"74","DOI":"10.6065\/apem.2015.20.2.74","article-title":"Alternative biomarkers for assessing glycemic control in diabetes: fructosamine, glycated albumin, and 1,5-anhydroglucitol","volume":"20","author":"Lee","year":"2015","journal-title":"Ann Pediatr Endocrinol Metab"},{"issue":"1\u20132","key":"10.1016\/j.diabres.2026.113216_b0230","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0168-8227(91)90031-8","article-title":"Correction of fructosamine value for serum albumin and globulin concentrations","volume":"13","author":"Kunika","year":"1991","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"10.1016\/j.diabres.2026.113216_b0240","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2337\/diacare.26.1.163","article-title":"Discordance between HbA1c and fructosamine: evidence for a glycosylation gap and its relation to diabetic nephropathy","volume":"26","author":"Cohen","year":"2003","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.diabres.2026.113216_b0245","article-title":"Association among glycemic biomarkers in korean adults: hemoglobin A1c, fructosamine, and glycated albumin","volume":"67","author":"Choi","year":"2021","journal-title":"Clin Lab"},{"issue":"8","key":"10.1016\/j.diabres.2026.113216_b0255","doi-asserted-by":"crossref","first-page":"994","DOI":"10.2337\/dc17-0636","article-title":"The fallacy of average: how using HbA1c alone to assess glycemic control can be misleading","volume":"40","author":"Beck","year":"2017","journal-title":"Diabetes Care"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882272600135X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882272600135X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T05:41:49Z","timestamp":1793598109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016882272600135X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":51,"alternative-id":["S016882272600135X"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113216","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Navigating the discordance: a comprehensive review of HbA1c-glycemia mismatch in clinical practice","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113216","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113216"}}